Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0019693 (
HIV
)
170,526
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Thirty-seven isolates from 10
HIV
-negative and 26
HIV
-positive patients in Mato Grosso were evaluated. Direct examination, culturing and chemotyping of species were performed.
Ketoconazole
, itraconazole, voriconazole, fluconazole and amphotericin B were evaluated. Thirty-seven yeasts of Cryptococcus spp were identified, of which 26 were from
HIV
-positive patients (25 Cryptococcus neoformans and one Cryptococcus gattii) and 10 from
HIV
-negative patients (five Cryptococcus neoformans and five Cryptococcus gattii). The Cryptococcus neoformans clinical isolates from
HIV
-positive patients showed resistance (8% and 8.7%) and dose-dependent susceptibility (20% and 17.4%) to fluconazole and itraconazole, respectively. Among the Cryptococcus neoformans isolates from
HIV
-negative patients, there was dose-dependent susceptibility (40%) to fluconazole. Cryptococcus gattii isolates from
HIV
-negative patients were shown to be susceptible to all antifungal agents, except for one isolate of Cryptococcus gattii that showed dose-dependent susceptibility to fluconazole (20%). The Cryptococcus gattii isolate from an
HIV
-positive patient showed resistance to fluconazole (MIC > or = 256 (1/4)g/ml) and itraconazole (MIC = 3 (1/4)microg/ml).
...
PMID:[First description of phenotypic profile and in vitro drug susceptibility of Cryptococcus spp yeast isolated from HIV-positive and HIV-negative patients in State of Mato Grosso]. 2020 51
HIV
and AIDS are major public health problems in Cameroon where the
HIV
prevalence is 5.5%. Candidiasis is the leading opportunistic mycosis in
HIV
and AIDS patients. The objective of this study was to determine the
in vitro
antifungal susceptibility pattern of
Candida albicans
in
HIV
and AIDS patients to eight antifungal agents in the Nylon Health District of Douala in Cameroon. Three hundred and four
HIV
and AIDS patients were recruited between March and August 2007 to participate in a cross-sectional study. All subjects who fulfilled the inclusion criteria were enrolled. Informed consent was obtained from all subjects before samples were collected. Three samples comprising oral swabs, vagina/urethra swabs and a mid-stream urine were collected from each subject. Specimens were cultured on sabouraud dextrose agar and
C. albicans
isolates were identified using the germ tube technique. The disk diffusion method was used for antifungal susceptibility testing using eight antifungal agents. The prevalence of candidiasis in the study population was 67.8% (95% CI: 62.5-73.1%) and that of
C. albicans
was 42.8% (95% CI: 37.2-48.4%). Oral swabs had the highest prevalence of
C. albicans
followed by vaginal/urethral samples (52.6% vs. 29.7% respectively). Forty (30.8%) subjects had
C. albicans
infection at more than one collection site. There was a statistically significant difference in the infectivity of
C. albicans
with age, sex and site of infection (P<0.05).
C. albicans
isolates were most sensitive to ketoconazole (80%) followed by econazole (64.6%) while fluconazole and 5-flurocytosin recorded the poorest sensitivities (22.9%
vs
24.6%, respectively). There was a statistically significant difference in the sensitivity pattern of antifungal agents with respect to the site of isolation of the organism (P<0.05).
Ketoconazole
is the drug of choice for the treatment of
C. albicans
infection in
HIV
and AIDS patients in the Nylon Health District of Douala, Cameroon.
...
PMID:
In vitro
Antifungal Susceptibility Patterns of
Candida Albicans
from HIV and AIDS Patients Attending the Nylon Health District Hospital in Douala, Cameroon. 2829 76
This case study presents an unusual pathogenic association among several cranioencephalic lesions characterized by the association of osteitis of the cranial vault, due to Aspergillus fumigatus, with underlying thrombophlebitis complicated by intracranial hypertension resulting from hydrocephalus. The study involved a 43-year old
HIV
(human immunodeficiency virus) negative man with multi-recurrent infection of the frontal scalp. The patient was successfully treated with cerebrospinal fluid diversion (CFD),
Ketoconazole
and low molecular weight heparin. This study describes the different pathophysiological and therapeutic features of this exceptional pathogenic association.
...
PMID:[Hydrocephaly resulting from thrombophlebitis of the superior sagittal sinus due to osteitis of the cranial vault caused by Aspergillus fumigatus in an immunocompetent patient]. 3101 98
<< Previous
1
2